Utility of trimethylamine N-oxide (TMAO) as a biomarker for risk stratification in chronic kidney disease: a multicenter observational study. [PDF]
Lei Y +14 more
europepmc +1 more source
Trimethylamine-N-oxide (TMAO) mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis. [PDF]
Zhou D, Zhang J, Xiao C, Mo C, Ding BS.
europepmc +1 more source
Gut Microbiota-Derived Metabolite and Heart Failure with Reduced Ejection Fraction (HFrEF): Elevated Trimethylamine N-Oxide (TMAO) as a Potential Biomarker. [PDF]
Kuan SW +5 more
europepmc +1 more source
Associations of Diet with Urinary Trimethylamine-N-Oxide (TMAO) and Its Precursors among Free-Living 10-Year-Old Children: Data from SMBCS. [PDF]
Dai Y +11 more
europepmc +1 more source
Trimethylamine-N-oxide (TMAO) and risk of incident cardiovascular events in the multi ethnic study of Atherosclerosis. [PDF]
Budoff MJ +12 more
europepmc +1 more source
Association of Trimethylamine N-Oxide (TMAO) with the Clinical Severity of Hidradenitis Suppurativa (Acne Inversa). [PDF]
Barrea L +9 more
europepmc +1 more source
Sex-specific differences in trimethylamine N-oxide (TMAO) concentrations before and after cardiac rehabilitation in acute myocardial infarction patients. [PDF]
Baranyi A +13 more
europepmc +1 more source
Interleukin-8 (IL-8) as a Potential Mediator of an Association between Trimethylamine N-Oxide (TMAO) and Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) among African Americans at Risk of Cardiovascular Disease. [PDF]
Baginski AM +4 more
europepmc +1 more source
Trimethylamine N-Oxide (TMAO) Plasma Levels in Patients with Different Stages of Chronic Kidney Disease. [PDF]
Ribeiro M +6 more
europepmc +1 more source
Trimethylamine N-oxide (TMAO) Is not Associated with Cardiometabolic Phenotypes and Inflammatory Markers in Children and Adults. [PDF]
Andraos S +9 more
europepmc +1 more source

